Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 2/3 3Phase 1 3Phase 3 2Phase 1/2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 4Esophageal Neoplasms 3Immunotherapy Gastrict Cancer 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 7Radiotherapy 5S 1 (combination) 3Paclitaxel 3Fluorouracil 3Capecitabine 3toripalimab 1tegafur-gimeracil-oteracil 1nimotuzumab 1nedaplatin 1apatinib 1Tegafur 1TP protocol 1Surgical Procedures, Operative 1Radiation 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Immunotherapy 1Fluorodeoxyglucose F18 1Drug Therapy 1Cetuximab 1Carboplatin 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Esophageal Neoplasms × S 1 (combination) × Clear all
NCT05817201 2023-04-18

Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy

Taizhou Hospital

Phase 2/3 Unknown
60 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02979691 2020-07-21

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

ChineseAMS

Phase 2/3 Completed
350 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Peking University

Phase 2/3 Terminated
4 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡